UCLA
Bipolar Funding Consortium Aims to Unravel Disorder's Genetics, Reduce Healthcare Disparities
Premium
The ambitious set of projects funded by BD² aims to improve our understanding of bipolar disorder and inform care across the entire spectrum of research and clinical practice.
Researchers in Australia, Germany, and the US are in the early stages of developing a prostate cancer radiopharmaceutical they say could be manufactured in-house via a desktop machine.
Survey Suggests Polygenic Embryo Screening Has Higher Public Acceptance Than Anticipated
A national survey of more than 6,800 US participants asked about attitudes towards polygenic embryo screening, germline genome editing, and SAT prep courses.
ImmPact Bio to Begin Phase I/II Trial of Bispecific CAR T-Cell Therapy in Aggressive Lymphoma
The FDA cleared the firm's investigational new drug application, permitting it to begin a clinical trial of IMPT-314, an autologous CAR T-cell therapy targeting CD19 and CD20.
Cancer Patients in Early Trial Receive Personalized, CRISPR-Edited T-Cell Therapy
The PACT Pharma-funded study found that the edited T cells trafficked to patients' solid tumors and indicated that the treatment was well tolerated.